Steven H. Holtzman, Chairman and CEO at INFINITY PHARMACEUTICALS, INC. (INFI), bought 5,000 shares at $9.12 ($46K) on 2007-09-14, disclosed to the SEC on 2007-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| BIIB | SELL | 2014-11-12 | $578K | — | Filing → |
| BIIB | SELL | 2014-10-02 | $579K | — | Filing → |
| BIIB | SELL | 2014-05-20 | $353K | — | Filing → |